T8405

Vardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes

(E)-dec-3-enoic acid (trans-3-decenoic acid) participates in the production of nanomaterials and can be used to study neurological diseases.

4-methylnonanoic acid is a RIFM fragrance and one of the sources of mutton odor.

2-Butylhexanoic acid is an intermediate in organic synthesis.

2-Propylheptanoic acid (2-N-PROPYL-1-HEPTANOIC ACID) is a structural analogue of valproic acid and a raw material for the production of sorbitol mono(2-propyl)heptyl ester.

2-Ethyloctanoic acid is a raw material for the production of dyes and can be used as a stabilizer and catalyst in the production of coatings.

Vardenafil-D5 hydrochloride is the deuterium-labeled version of Vardenafil hydrochloride (TMSM-2380). Vardenafil dihydrochloride is a highly selective and orally active phosphodiesterase 5 (PDE5) inhibitor, with an IC50 of 0.7 nM. It displays IC50 values of 180 nM and 11 nM for PDE1 and PDE6, respectively, while for PDE3 and PDE4, the IC50 is greater than 1000 nM. This compound non-competitively inhibits the hydrolysis of cyclic guanosine monophosphate (cGMP), leading to increased cGMP levels. Vardenafil dihydrochloride is useful for studying conditions such as erectile dysfunction, hepatitis, and diabetes.